Interestingly, the CE in STMN2 was not identified in any of the AD datasets, and the event in ARHGAP32 was detected at very low levels in the ROSMAP, MayoRNAseq, and MSBB BA36 datasets but without significant differences between AD patients and controls. This evidence concerns the gene ARHGAP32 and Alzheimer disease.